9620 Medical Center Drive
301-340-3188 or 888-267-4436
OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.
OriGene also dedicates itself to the market of companion diagnostics and OriGene recently developed a line of Antibodies. UltraMAB™, the ultra-specific antibody for anatomic pathology. The specificity of UltraMABs ™have been tested against breakthrough technology High Density Protein MicroArray to ensure every UltraMAB™ only recognizes its own targets without cross reacting with other proteins. In addition, to UltraMAB™, OriGene provides TrueMAB™ mouse monoclonal antibodies for the research market. TrueMABs are developed against authentic protein antigens and have been validated extensively for various immunoassays